Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Lupus. 2016 Sep 29;26(6):588–597. doi: 10.1177/0961203316668417

Table 1.

Subject charactersitics

N (%) or mean ± SD or median (Q1–Q3) Reference data from controls or standard ranges
SLE patients, n = 51
Female 47 (92%) 39 (76%); p=0.06
Age (years) 48.8 ± 14.3 44.9 ± 11.1; p=0.12
Disease duration (months) 50 (24.5–148)
Members of SLEx registry 31 (61%)
NPSLE 4 (8%)
BMI (kg/m2) 29 (6.5) 20–25 normal, 25–30 overweight, 30–35 obese, 35+ clinically obese
Current smoker 6 (12%)
Hypertension 9 (18%) ≥140/90 mm Hg
Fatigue (score) 5.0 ± 1.7 2.3 ± 0.7; p<0.0001
Anxiety (score) 6 (3–12) 0–7 non-case, 8–10 borderline, 11+ case
Depression (score) 8 (6–12) As anxiety
Current steroids 18 (35%)
MoCA (score) (n=50) 26 (24–28) 0–30. Normal ≥26
ACER (score) (n=50) 91 (87–94) 0–100. Normal ≥88
MMSE (score) (n=50) 28 (27–30) 0–30. Normal ≥27
NART (score) (n=50) 34 (27–39) 40 (34–42); p=0.0008

ACER = Addenbrooke’s Cognitive Examination – Revised, BMI = body mass index, MoCA = Montreal Cognitive Assessment, MMSE = Mini Mental State Examination, NART = National Adult Reading Test